Ardelyx (ARDX) Invested Capital (2019 - 2023)
Ardelyx's (ARDX) quarterly Invested Capital came in at $27.1 million in Q2 2023, up 2.57% YoY from $26.4 million in Q2 2022, and up 0.64% on a QoQ basis from $26.9 million in Q1 2023.
Ardelyx (ARDX) Invested Capital (2019 - 2023) Analysis & Trends
Ardelyx (ARDX) has 5 years of Invested Capital data on file, last reported at $27.1 million in Q2 2023.
- Quarterly Invested Capital rose 2.57% year-over-year to $27.1 million in Q2 2023, while the trailing twelve-month figure through Mar 2024 was $27.1 million (down 74.6% YoY) and the FY2022 annual result came in at $26.7 million, down 17.21% from the prior year.
- Invested Capital climbed to $27.1 million in Q2 2023, from $26.9 million in the prior quarter.
- In the past five years, Invested Capital ranged from a high of $44.4 million in Q3 2021 to a low of $1.2 million in Q4 2019.
- A 5-year average of $22.5 million and a median of $26.5 million in 2022 frame the typical range for Invested Capital.
- Annual changes were most pronounced in 2021 — Invested Capital surged 674.27% — and 2022, when it sank 40.28%.
- Tracing ARDX's Invested Capital over 5 years: stood at $1.2 million in 2019, then soared by 252.24% to $4.2 million in 2020, then surged by 674.27% to $32.3 million in 2021, then retreated by 17.21% to $26.7 million in 2022, then rose by 1.28% to $27.1 million in 2023.
- The last three Invested Capital figures came in at $27.1 million (Q2 2023), $26.9 million (Q1 2023), and $26.7 million (Q4 2022), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Invested Cap. (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 190.90 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 2.57 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 380.00 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | - |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | - |
| 10 | Ardelyx | 1.01 Bn | 729.71 Mn | 115.12 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2023 | 27.05 Mn |
| Mar 31, 2023 | 26.88 Mn |
| Dec 31, 2022 | 26.71 Mn |
| Sep 30, 2022 | 26.54 Mn |
| Jun 30, 2022 | 26.37 Mn |
| Mar 31, 2022 | 26.14 Mn |
| Dec 31, 2021 | 32.26 Mn |
| Sep 30, 2021 | 44.44 Mn |
| Jun 30, 2021 | 36.11 Mn |
| Mar 31, 2021 | 16.67 Mn |
| Dec 31, 2020 | 4.17 Mn |
| Jun 30, 2020 | 13.72 Mn |
| Mar 31, 2020 | 7.44 Mn |
| Dec 31, 2019 | 1.18 Mn |